U.S. Clinical Nutrition Market Size By Product [Infant Nutrition (Milk Based, Soy Based, Organic), Parenteral Nutrition (Amino Acids, Fats, Carbohydrates), Enteral Nutrition (Standard Composition, Disease Specific Composition)], By Consumer (Child, Adult), Application Potential, Competitive Market Share & Forecast, 2020 – 2026

Report Content

Chapter 1.    Methodology

1.1. Methodology   

1.2. Market definition

1.3. Forecast parameters

1.4. Data sources

1.4.1.    Secondary

1.4.1.1.    Paid sources

1.4.1.2.    Unpaid sources

1.4.2.    Primary

Chapter 2.    Executive Summary

2.1. U.S. clinical nutrition industry 360⁰ synopsis, 2015 - 2026

2.1.1.    Business trends

Chapter 3.    U.S. Clinical Nutrition Industry Insights

3.1. Industry segmentation

3.2. Product landscape, 2015 – 2026

3.3. Industry ecosystem analysis

3.4. Distribution channel analysis

3.5. Industry impact forces

3.5.1.    Growth drivers

3.5.1.1.    Increasing metabolic disorders and other chronic diseases

3.5.1.2.    Junk food habits leading to malnourishment in U.S.

3.5.1.3.    Rising geriatric population

3.5.1.4.    Increasing rate of pre-mature birth & birth rate in U.S.

3.5.1.5.    Increasing adoption of home healthcare in U.S.

3.5.2.    Industry pitfalls & challenges

3.5.2.1.    Stringent government regulations in U.S.

3.6. Growth potential analysis

3.6.1.    By product

3.6.2.    By consumer

3.7. Regulatory landscape

3.8. Reimbursement scenario

3.9. Pipeline analysis

3.10.    Patent landscape

3.11.    Porter’s analysis

3.12.    Competitive landscape, 2018

3.12.1. Company matrix analysis, 2018

3.12.2. Company market share analysis, 2018

3.13.    PESTEL analysis

Chapter 4.    U.S. Clinical Nutrition Market, By Product

4.1. Key segment trends

4.2. Infant Nutrition

4.2.1.    Market size, 2015 – 2026 (USD Million)

4.2.2.    Milk Based

4.2.2.1. Market size, 2015 – 2026 (USD Million)

4.2.3.    Soy Based

4.2.3.1. Market size, 2015 – 2026 (USD Million)

4.2.4.    Organic

4.2.4.1. Market size, 2015 – 2026 (USD Million)

4.2.5.    Others

4.2.5.1. Market size, 2015 – 2026 (USD Million)

4.3. Parenteral Nutrition

4.3.1.    Market size, 2015 – 2026 (USD Million)

4.3.2.    Amino Acids

4.3.2.1. Market size, 2015 – 2026 (USD Million)

4.3.3.    Fats

4.3.3.1. Market size, 2015 – 2026 (USD Million)

4.3.4.    Carbohydrates

4.3.4.1. Market size, 2015 – 2026 (USD Million)

4.3.5.    Others

4.3.5.1. Market size, 2015 – 2026 (USD Million)

4.4. Enteral Nutrition

4.4.1.    Market size, 2015 – 2026 (USD Million)

4.4.2.    Standard composition

4.4.2.1. Market size, 2015 – 2026 (USD Million)

4.4.3.    Disease specific composition

4.4.3.1. Market size, 2015 – 2026 (USD Million)

Chapter 5.    U.S. Clinical Nutrition Market, By Consumer

5.1. Key segment trends

5.2. Child

5.2.1.    Market size, 2015 – 2026 (USD Million)

5.3. Adult

5.3.1.    Market size, 2015 – 2026 (USD Million)

Chapter 6.    Company Profiles

6.1.    Competitive dashboard

6.2.    Abbott Laboratories

6.2.1.    Business overview

6.2.2.    Financial data

6.2.3.    Product landscape

6.2.4.    Strategic outlook

6.2.5.    SWOT analysis

6.3.    B Braun Melsungen AG

6.3.1.    Business overview

6.3.2.    Financial data

6.3.3.    Product landscape

6.3.4.    Strategic outlook

6.3.5.    SWOT analysis

6.4.    Baxter International Inc

6.4.1.    Business overview

6.4.2.    Financial data

6.4.3.    Product landscape

6.4.4.    Strategic outlook

6.4.5.    SWOT analysis

6.5.    Danone

6.5.1.    Business overview

6.5.2.    Financial data

6.5.3.    Product landscape

6.5.4.    Strategic outlook

6.5.5.    SWOT analysis

6.6.    Fresenius Kabi

6.6.1.    Business overview

6.6.2.    Financial data

6.6.3.    Product landscape

6.6.4.    Strategic outlook

6.6.5.    SWOT analysis

6.7.    Hospira

6.7.1.    Business overview

6.7.2.    Financial data

6.7.3.    Product landscape

6.7.4.    Strategic outlook

6.7.5.    SWOT analysis

6.8.        Mead Johnson

6.8.1.    Business overview

6.8.2.    Financial data

6.8.3.    Product landscape

6.8.4.    Strategic outlook

6.8.5.    SWOT analysis

6.9.    Nestle

6.9.1.    Business overview

6.9.2.    Financial data

6.9.3.    Product landscape

6.9.4.    Strategic outlook

6.9.5.    SWOT analysis

6.10.    Perrigo

6.10.1. Business overview

6.10.2. Financial data

6.10.3. Product landscape

6.10.4. Strategic outlook

6.10.5. SWOT analysis

   

   

Data Tables
TABLE 1.    U.S. clinical nutrition industry 360⁰ synopsis, 2015 – 2026

TABLE 2.    Industry impact forces

TABLE 3.    Clinical nutrition pipeline analysis

TABLE 4.    Patent landscape for enteral nutrition

TABLE 5.    Patent landscape for parenteral nutrition

TABLE 6.    U.S. infant nutrition market size, 2015 - 2019 (USD Million)

TABLE 7.    U.S. infant nutrition market size, 2020 - 2026 (USD Million)

TABLE 8.    U.S. market size, by milk based, 2015 - 2019 (USD Million)

TABLE 9.    U.S. market size, by milk based, 2020 - 2026 (USD Million)

TABLE 10.    U.S. market size, by soy based, 2015 - 2019 (USD Million)

TABLE 11.    U.S. market size, by soy based, 2020 - 2026 (USD Million)

TABLE 12.    U.S. market size, by organic formulas, 2015 - 2019 (USD Million)

TABLE 13.    U.S. market size, by organic formulas, 2020 - 2026 (USD Million)

TABLE 14.    U.S. market size, by others, 2015 - 2019 (USD Million)

TABLE 15.    U.S. market size, by others, 2020 - 2026 (USD Million)

TABLE 16.    U.S. enteral nutrition market size, 2015 - 2019 (USD Million)

TABLE 17.    U.S. enteral nutrition market size, 2020 - 2026 (USD Million)

TABLE 18.    U.S. market size, by standard composition, 2015 - 2019 (USD Million)

TABLE 19.    U.S. market size, by standard composition, 2020 - 2026 (USD Million)

TABLE 20.    U.S. market size, by disease specific composition, 2015 - 2019 (USD Million)

TABLE 21.    U.S. market size, by disease specific composition, 2020 - 2026 (USD Million)

TABLE 22.    U.S. parenteral nutrition market size, 2015 - 2019 (USD Million)

TABLE 23.    U.S. parenteral nutrition market size, 2020 - 2026 (USD Million)

TABLE 24.    U.S. market size, by amino acids, 2015 - 2019 (USD Million)

TABLE 25.    U.S. market size, by amino acids, 2020 - 2026 (USD Million)

TABLE 26.    U.S. market size, by fats, 2015 - 2019 (USD Million)

TABLE 27.    U.S. market size, by fats, 2020 - 2026 (USD Million)

TABLE 28.    U.S. market size, by carbohydrates, 2015 - 2019 (USD Million)

TABLE 29.    U.S. market size, by carbohydrates, 2020 - 2026 (USD Million)

TABLE 30.    U.S. market size, by others, 2015 - 2019 (USD Million)

TABLE 31.    U.S. market size, by others, 2020 - 2026 (USD Million)
 

Charts & Figures

FIG. 1    Industry segmentation

FIG. 2    U.S. clinical nutrition market, 2015- 2026 (USD Million)

FIG. 3    Industry ecosystem analysis

FIG. 4    Distribution channel analysis

FIG. 5    Profit margin across the value chain

FIG. 6    Persons aged 60 and above in North America (Million)

FIG. 7    Growth potential analysis, by product

FIG. 8    Company share analysis, 2016

FIG. 9    Strategy dashboard, 2016

FIG. 10    Porter’s analysis

FIG. 11    PESTEL analysis

FIG. 12    U.S. clinical nutrition market share by product, 2019 & 2026